Annual report pursuant to Section 13 and 15(d)

Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details)

v3.24.0.1
Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:        
Net operating loss, capital loss amount and research & experimentation credit carryforwards $ 6,752 $ 10,685    
Capitalized research and development costs 8,937 8,205    
Capitalized costs to self-constructed property 10,593 7,892    
Non-cash compensation 2,360 2,534    
Accrued liabilities 1,655 1,472    
Reserves and other 4,624 1,960    
Lease liabilities 3,902      
Intangibles 1,070 224    
Deferred tax assets, gross 39,893 32,972    
Valuation allowance (714) (3,323) $ (4,378) $ (22,348)
Net deferred tax assets 39,179 29,649    
Deferred tax liabilities:        
Depreciation (1,712) (1,390)    
Intangibles (28,470) (28,319)    
Right-of-use assets (3,647)      
Other (605) (534)    
Deferred tax liabilities, gross (34,434) (30,243)    
Total   $ (594)    
Total $ 4,745